icmr vaccine trial
15% Trust Crash From What Is Data Transparency Silence
78% of Indian citizens say the ICMR’s decision to hide roughly 15% of the COVAX-I vaccine trial data shattered public trust, prompting calls for full disclosure. The controversy revolves around missing laboratory results and adverse-event records that could shift the reported efficacy from about 70% to a higher figure.